ArticleRMD open2026

Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.

Anisha Bharadwaj Dua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.